PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea flag South Korea · Delayed Price · Currency is KRW
302,000
+5,000 (1.68%)
Apr 10, 2026, 3:30 PM KST

PharmaResearch Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,085,7254,187,0282,727,2831,116,952697,316818,025
Market Cap Growth
-8.90%53.52%144.17%60.18%-14.76%48.15%
Enterprise Value
2,719,5733,887,6132,575,782990,868612,568761,136
Last Close Price
297000.00403000.00259933.95107975.2268322.0379394.26
PE Ratio
19.8925.3629.6314.5917.1817.52
Forward PE
15.2023.9622.0612.5510.9214.49
PS Ratio
5.757.817.794.283.585.31
PB Ratio
4.265.784.782.421.882.49
P/TBV Ratio
4.686.365.382.772.273.10
P/FCF Ratio
20.1127.2926.8221.1216.5518.32
P/OCF Ratio
16.8522.8619.7517.2011.7412.53
EV/Sales Ratio
5.077.257.363.803.154.94
EV/EBITDA Ratio
12.0817.0418.449.508.0112.27
EV/EBIT Ratio
12.9918.3120.4310.749.2914.50
EV/FCF Ratio
17.7225.3425.3318.7414.5317.05
Debt / Equity Ratio
0.290.290.370.070.180.20
Debt / EBITDA Ratio
0.930.931.490.330.871.06
Debt / FCF Ratio
1.391.392.050.651.581.47
Net Debt / Equity Ratio
-0.55-0.55-0.40-0.27-0.32-0.28
Net Debt / EBITDA Ratio
-1.76-1.76-1.64-1.21-1.54-1.47
Net Debt / FCF Ratio
-2.62-2.62-2.25-2.38-2.79-2.04
Asset Turnover
0.560.560.500.520.430.41
Inventory Turnover
1.791.791.841.902.552.40
Quick Ratio
6.076.075.842.964.043.86
Current Ratio
6.926.926.753.894.564.31
Return on Equity (ROE)
25.99%25.99%17.23%18.53%12.41%15.80%
Return on Assets (ROA)
13.97%13.97%11.33%11.38%9.10%8.78%
Return on Invested Capital (ROIC)
48.19%49.64%28.57%23.98%21.57%19.29%
Return on Capital Employed (ROCE)
22.70%22.70%16.30%19.70%15.60%13.80%
Earnings Yield
5.35%3.94%3.38%6.85%5.82%5.71%
FCF Yield
4.97%3.67%3.73%4.74%6.04%5.46%
Dividend Yield
1.26%--0.88%0.97%0.76%
Payout Ratio
7.10%7.10%10.96%9.84%15.56%10.77%
Buyback Yield / Dilution
-7.41%-7.41%2.50%-5.85%0.76%-5.74%
Total Shareholder Return
-6.15%-7.41%2.50%-4.96%1.73%-4.99%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.